Abstract:Abstract Purpose: Recent epidemiological and clinical studies have suggested the benefit of aspirin for patients with cancer, which inspired increasing efforts to demonstrate the anticancer ability of aspirin and reveal the molecular mechanisms behind. Nevertheless, the anticancer activity and related mechanisms of aspirin remain largely unknown. This study aimed to confirm this observation, and more importantly, to investigate the potential target contributed to the anticancer of aspirin. Experimental Design: A homogeneous time-resolved fluorescence (HTRF) assay was used to examine the impact of aspirin on heparanase. Streptavidin pull-down, surface plasmon resonance (SPR) assay, and molecular docking were performed to identify heparanase as an aspirin-binding protein. Transwell, rat aortic rings, and chicken chorioallantoic membrane model were used to evaluate the antimetastasis and anti-angiogenesis effects of aspirin, and these phenotypes were tested in a B16F10 metastatic model, MDA-MB-231 metastatic model, and MDA-MB-435 xenograft model. Results: This study identified heparanase, an oncogenic extracellular matrix enzyme involved in cancer metastasis and angiogenesis, as a potential target of aspirin. We had discovered that aspirin directly binds to Glu225 region of heparanase and inhibits the enzymatic activity. Aspirin impeded tumor metastasis, angiogenesis, and growth in heparanase-dependent manner. Conclusions: In summary, this study has illustrated heparanase as a target of aspirin for the first time. It provides insights for a better understanding of the mechanisms of aspirin in anticancer effects, and offers a direction for the development of small-molecule inhibitors of heparanase. Clin Cancer Res; 23(20); 6267–78. ©2017 AACR.

Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study

Abstract 3105: Design principle of heparanase inhibitors: A combined in vitro and in silico study

A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo

An Artificial Mirna Against Hpse Suppresses Melanoma Invasion Properties, Correlating With A Down-Regulation Of Chemokines And Mapk Phosphorylation

Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances

Chemical toolbox to interrogate Heparanase-1 activity

Aspirin Inhibits Cancer Metastasis and Angiogenesis Via Targeting Heparanase

Figure S1 from Aspirin Inhibits Cancer Metastasis and Angiogenesis Via Targeting Heparanase

Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors

Lentiviral Mir30-Based Rna Interference Against Heparanase Suppresses Melanoma Metastasis With Lower Liver And Lung Toxicity

Synthesis of Novel Glycolipid Mimetics of Heparan Sulfate and Their Application in Colorectal Cancer Treatment in a Mouse Model

Heparanase Promotes Tumor Growth and Liver Metastasis of Colorectal Cancer Cells by Activating the p38/MMP1 Axis

[Inhibitory Effect of Silencing Heparanase Expression with Antisense Oligodeoxynucleotide on Invasive Capability of Human Esophageal Squamous Cancer Cell Line TE-13].

A Fluorogenic Green Merocyanine-Based Probe to Detect Heparanase-1 Activity

Association between heparinase and tumors

Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase

Synthesis of alkyne- and azide-functionalised aziridine and epoxide carbocycles for development of selective glucuronidase mechanism-based inhibitors

A New Synthesized Dicarboxylated Oxy-Heparin Efficiently Attenuates Tumor Growth and Metastasis

In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment

Interacting polymer-modification enzymes in heparan sulfate biosynthesis